Heren HealthLtd Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Chenhui Zhao

İcra Kurulu Başkanı

CN¥630.4k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.5yrs
CEO sahipliği	0.02%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	4.9yrs

Son yönetim güncellemeleri

Recent updates

Subdued Growth No Barrier To Heren Health Co.,Ltd. (SZSE:300550) With Shares Advancing 35%

Oct 02

Heren Health Co.,Ltd.'s (SZSE:300550) Shares Climb 29% But Its Business Is Yet to Catch Up

Aug 18

CEO

Chenhui Zhao (45 yo)

2.5yrs

Görev süresi

CN¥630,400

Tazminat

Mr. Chenhui Zhao is General Manager of Heren Health Co., Ltd. since May 18, 2022 and serves as its Chairman since May 17, 2023.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Chenhui Zhao	Chairman & GM	1.5yrs	CN¥630.40k	0.020% CN¥ 771.6k
Hong Xia	Non-Independent Director	10.9yrs	CN¥50.00k	Veri yok
Junbing Chen	Supervisor	10.9yrs	Veri yok	Veri yok
Yuru Cai	Independent Director	4.9yrs	CN¥50.00k	Veri yok
Weirong Hong	Independent Director	4.9yrs	CN¥50.00k	Veri yok
Hai Huang	Independent Director	4.9yrs	CN¥50.00k	Veri yok
Yi Wang	Non Independent Director	1.5yrs	Veri yok	Veri yok
Yuhua Huang	Non Independent director	1.5yrs	Veri yok	Veri yok
Ting Lu	Chairman of the Supervisory Board	1.5yrs	Veri yok	Veri yok

4.9yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300550 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.9 yıldır).

Heren HealthLtd Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Heren Health Co., Ltd., Annual General Meeting, May 15, 2024

Heren Health Co., Ltd. Announces Management Changes

Insufficient new directors

Insufficient new directors

High number of new directors

High number of new directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.068 (vs CN¥0.047 in 3Q 2023)

Subdued Growth No Barrier To Heren Health Co.,Ltd. (SZSE:300550) With Shares Advancing 35%

Heren Health Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: CN¥0.044 loss per share (vs CN¥0.017 loss in 2Q 2023)

Heren Health Co.,Ltd.'s (SZSE:300550) Shares Climb 29% But Its Business Is Yet to Catch Up

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Heren Health Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Heren Health Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 25 June 2024

Heren Health Co., Ltd Proposes Final Dividend for 2023

Heren Health Co., Ltd., Annual General Meeting, May 15, 2024

First quarter 2024 earnings released: CN¥0.002 loss per share (vs CN¥0.004 profit in 1Q 2023)

Heren Health Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

New minor risk - Share price stability

Heren Health Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.02 in 3Q 2022)

Heren Health Co., Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Second quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.051 profit in 2Q 2022)

Heren Health Co., Ltd. Announces Management Changes

Insufficient new directors

Topchoice Medical Corporation (SHSE:600763) cancelled the acquisition of Heren Health Co., Ltd. (SZSE:300550) from Hangzhou Panyuan Investment Co., Ltd. from Hangzhou Panyuan Investment Co., Ltd.

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.051 (vs CN¥0.048 in 2Q 2021)

High number of new directors

Heren Health Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 07, 2022

Heren Health Co., Ltd. Approves Cash Dividend for the Year 2021

Topchoice Medical Corporation (SHSE:600763) agreed to acquire Heren Health Co., Ltd. (SZSE:300550) from Hangzhou Panyuan Investment Co., Ltd. from Hangzhou Panyuan Investment Co., Ltd. for approximately 770 million.

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new directors

Third quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.079 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.048 (vs CN¥0.018 in 2Q 2020)

Heren Health Co., Ltd. Approves Dividend for 2020

Heren Health Co., Ltd. Proposes Final Cash Dividend for the Year 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.007 in 1Q 2020)

New 90-day low: CN¥17.36

New 90-day low: CN¥17.80

New 90-day low: CN¥20.01

Third quarter earnings released

First half earnings released

Heren Health Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥23.63

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş